A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
TipRanks on MSN
MAIA Biotechnology announces significant insider buying
An announcement from MAIA Biotechnology, Inc. ( ($MAIA) ) is now available. On December 11, 2025, MAIA Biotechnology, Inc. announced significant ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
TipRanks on MSN
MAIA Biotechnology advances NSCLC treatment with ateganosine
MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an update. On December 10, 2025, MAIA Biotechnology announced a significant advancement in the ...
News-Medical.Net on MSN
Exclusive licensing agreement accelerates PHD inhibitor development for anemia in CKD patients
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and ...
News-Medical.Net on MSN
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
The Trump administration may have softened its language on China to maintain a truce in their trade war, but Congress is ...
Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...
Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...
Included in the 3,000-page bill approved Wednesday by the House is a provision to scrutinize American investments in China ...
Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results